CAMBRIDGE, Mass--(BUSINESS WIRE)--PixarBio Corporation today announced expansion of the leadership team, to maintain momentum toward multiple FDA approvals of non-opiate and non-addictive pain treatments in 2017.
Dr. Amer Khalil, PixarBio scientific advisory board member has accepted the role of Medical Director. Dr. Khalil, a Harvard trained Neurosurgeon is a long-time collaborator with PixarBio cofounder Frank Reynolds having worked for Mr. Reynolds at InVivo Therapeutics.
Help employers find you! Check out all the jobs and post your resume.
